Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 21, Status: Authorised

Ibuprofen product-specific bioequivalence guidance

Dolutegravir product-specific bioequivalence guidance

Levothyroxine product-specific bioequivalence guidance

Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 31, Status: Authorised

Medicinal Product master data for better regulation and better health - Network Data Steering Group (NDSG) recommendations for human Product Master Data implementation and data management

Annual accounts: Financial year 2024

Declaration on the qualification of an enterprise as a micro, small or medium-sized enterprise (SME)

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised